title: Angiotensin II induces cardiovascular hypertrophy in perindopril-treated rats.
abstract: OBJECTIVE
  To investigate whether angiotensin II (Ang II) exerts a direct effect on cardiovascular hypertrophy in the spontaneously hypertensive rat or acts indirectly through elevation of blood pressure.
  
  
  METHODS
  Immature (7-week-old) and mature (14-week-old) spontaneously hypertensive rats were treated for 8 and 6 weeks, respectively, with an angiotensin converting enzyme inhibitor to block the in vivo production of Ang II and concomitantly infused with either a pressor dose of Ang II or noradrenaline.
  
  
  METHODS
  At the termination of treatment, vascular smooth muscle cell growth was assessed in the aorta and mesenteric arterioles.
  
  
  RESULTS
  In the young rats systolic blood pressure was not significantly different in the Ang II- and noradrenaline-infused groups. In the mature rats blood pressure was elevated in the Ang II-infused rats above that in the untreated and noradrenaline-infused groups, in which blood pressure was not significantly different. Ang II infusion induced cardiac hypertrophy and medial hypertrophy both in the aorta and in first-order mesenteric arterioles, accompanied by induction of smooth muscle polyploidy. The growth response to Ang II differed in the large and small vessels, with a marked induction of smooth muscle hyperplasia in the mesenteric arterioles but no change in cell number in the aorta. Infusion of noradrenaline did not induce cardiac or vascular hypertrophy, levels being similar to those in the rats treated with perindopril only.
  
  
  CONCLUSIONS
  These results suggest that Ang II can directly stimulate cardiac and vascular hypertrophy in the spontaneously hypertensive rat, independently of its effect on blood pressure.
authors.affiliation: Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia.
authors.forename: M J
authors.initials: MJ
authors.lastname: Black
authors.forename: J F
authors.initials: JF
authors.lastname: Bertram
authors.forename: J H
authors.initials: JH
authors.lastname: Campbell
authors.forename: G R
authors.initials: GR
authors.lastname: Campbell
mesh_terms: D000375:Aging / Q000502:physiology; D000804:Angiotensin II / Q000494:pharmacology*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000473:pathology; D001160:Arterioles / Q000187:drug effects / Q000473:pathology; D002319:Cardiovascular System / Q000187:drug effects* / Q000473:pathology; D006984:Hypertrophy; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000473:pathology / Q000502:physiology; D020913:Perindopril; D011003:Ploidies; D051381:Rats; D011918:Rats, Inbred SHR / Q000502:physiology; D011921:Rats, Inbred WKY; D013152:Splanchnic Circulation / Q000187:drug effects
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D007211:Indoles; D000804:Angiotensin II; D020913:Perindopril